Top Markets
#1 Derive Derive +33.22%
#2 Cross Cross +20.16%
#3 Geodnet Geodnet +12.50%
#4 Gama Token Gama Token +9.18%
#5 Biconomy Biconomy +9.08%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.14%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 The Bitcoin Bull The Bitcoin Bull +6.60%
#9 Cap Cap +6.32%
#10 Based Based +6.22%
Coin of the day
Derive Derive
Innstillinger
Språk
NORSK
Valuta
USD
Tema
National Graphite Corp. National Graphite Corp.

National Graphite Corp.

NGRC
Rangering i aksjer #35948
National Graphite Corp. (NGRC), operating through its subsidiary Biotech... National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Aksjekurs
$0.021
Sist synkronisert: 2026-08-13
Markedsverdi
$3.24M
Endring (1 dag)
0.00%
Endring (1 år)
-46.15%
Land
US
Handel National Graphite Corp. (NGRC)

Kategori

Financial Services
Aksjeprishistorikk for National Graphite Corp. (NGRC)
Høyeste sluttskurs: $0.02 den 2026-08-01

Laveste sluttskurs: $13.33 den 2012-08-01
Aksjeprishistorikk for National Graphite Corp. fra 2012 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 43.77%
2025 -40.77%
2024 -34.87%
2023 -38.75%
2022 -23.26%
2021 160.93%
2020 52.70%
2019 -17.60%
2018 -16.56%
2017 -18.16%
2016 -36.30%
2015 -74.52%
2014 -34.53%
2013 -95.88%
2012 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 $300.00 0.00%
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 $2.65 0.00%
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 $22.70 0.00%
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 $7.39 0.00%
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 $49.95 0.00%
US